World Congress on Genomics & Bioinformatics
Brisbane, Australia
Laszlo Takacs
University of Debrecen, Hungary
Title: Future of blood plasma profiling for medical diagnostics -a review of current trends
Biography
Biography: Laszlo Takacs
Abstract
Emerging research data indicates that circulating cell free nucleic acids, profiling of proteins and its variants and metabolites all carry significant diagnostics value. Here, current trends and the potentials in the integration of multiplatform data will be presented. As a specific example, protein epitope profiling technology with QuantiPlasmaTM biochips developed together with Randox Ltd. will be described. Variability of the proteome impacts epitopes, thus studying epitome dynamic is expected to open new avenues in protein biomarker research. To illustrate the value results of asymptomatic lung cancer detection will be shown. Integrated with imaging and established cancer biomarkers an epitomic blood test will be highly accurate in detecting asymptomatic lung cancer and reduce the number of imaging tests (Spiral CT) and unnecessary biopsies with 50%.